Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (26430043)
- License Information
-
More Information
Article History
Received: 17 February 2022
Revised: 28 April 2022
Accepted: 3 May 2022
First Online: 19 May 2022
Declarations
:
: KH is the inventor of patented LK derivatives used in this study, and own equity in a company involved with commercial development of the compounds for neurodegenerative disease.
: All animal experiments were conducted in accordance with the technical protocols for animal experiments approved by the Institutional Animal Care and Use Committee at Waseda University.
